"uuid:ID","name","instanceType","label","id","description","text"
"6ac5ab91-c977-4cea-a5a3-c3c58fa2d977","OBJ1","Objective","","Objective_1","Main objective","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg])."
"d1881113-be11-4e01-ae98-8b4f6ef9bc55","OBJ2","Objective","","Objective_2","Safety","To document the safety profile of the xanomeline TTS."
"d6d54858-2047-4788-b768-cff4be980f13","OBJ3","Objective","","Objective_3","Behaviour","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas."
